Evidence map›Paper›PMID 23062770›Full record

ReviewTrends in endocrinology and metabolism: TEM2013

Metabolic reprogramming by class I and II histone deacetylases.

Maria M Mihaylova, Reuben J Shaw

Open access · greenAbstract readReview
In one paragraph

Review in Trends in endocrinology and metabolism: TEM, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 95 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Maria M MihaylovaHoward Hughes Medical Institute, Molecular and Cell Biology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
Reuben J Shaw
Salk Institute for Biological Studies · US

Funding

Viral Vector Core (VVC)P30CA014195 · NCI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI Ye Zheng · 1985 to 2026
$82.8M
Tuberous Sclerosis-Pathway and PathogenesisP01CA120964 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI David J. Kwiatkowski · 2007 to 2026
$35.9M
Salk Institute Cancer Training GrantT32CA009370 · NCI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI Diana Clare Hargreaves, Jan Karlseder · 1986 to 2026
$8.6M
Role of LKB1 and AMPK in Metformin and TZD Control of Glucose Metabolism in LiverR01DK080425 · NIDDK · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI SHAW, REUBEN · 2007 to 2015
$3.6M
Howard Hughes Medical InstituteNCI NIH HHS P01 CA120964NCI NIH HHS P01CA120964NCI NIH HHS P30 CA014195NCI NIH HHS T32 CA009370NIDDK NIH HHS R01 DK080425
6 · The paper itself

Abstract

Accumulating evidence suggests that protein acetylation plays a major regulatory role in many facets of transcriptional control of metabolism. The enzymes that catalyze the addition and removal of acetyl moieties are the histone acetyl transferases (HATs) and histone deacetylases (HDACs), respectively. Several recent studies have uncovered novel mechanisms and contexts in which different HDACs play crucial roles in metabolic control. Understanding the role of class I and II HDACs in different metabolic programs during development, as well as in the physiology and pathology of the adult organism, will lead to novel therapeutics for metabolic disease. Here, we review the current understanding of how class I and class II HDACs contribute to metabolic control.

Indexed as

AMP-Activated Protein KinasesAnimalsGluconeogenesisHistone AcetyltransferasesHistone DeacetylasesHistonesHumansLipogenesisAMP-Activated Protein KinasesHistone AcetyltransferasesHistone DeacetylasesHistones

Identifiers

PMID23062770
PMCPMC3532556
OpenAlexW2003943923

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.